Long-term outcomes of bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch D Kröll, Y.

Slides:



Advertisements
Similar presentations
L Genser (2), A Soprani(1,2), Tabbara M (2), J Cady (1) 1- Clinique Geoffroy Saint Hilaire (Paris), 2- Service de Chirurgie Digestive et Hépato-Bilio-Pancréatique,
Advertisements

Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity Featured Article: Ricardo V. Cohen, M.D., Jose C. Pinheiro, M.D.,
Roles of Laparoscopic Sleeve Gastrectomy in Bariatric Surgery
ANALISI COMPARATIVA DELLA GASTRECTOMIA VERTICALE VS BENDAGGIO GASTRICO VS BYPASS GASTRICO IN PAZIENTI CON BMI
Lap-Band Surgery for Adolescents NYU Medical Center Program for Surgical Weight Loss George Fielding, MD Associate Professor of Surgery Evan P. Nadler,
Ivaylo Tzvetkov, Krasimir Shopov, Jordan Birdanov, Ivan Jurukov Hospital Doverie, Sofia, Bulgaria.
Morbid Obesity Surgery CDR Craig Shepps MD, FACS.
By Prof Dr WALEED IBRAHIM.  Obesity has been defined as excess body fat relative to lean body mass.  The most widely accepted measure of obesity is.
Sleeve gastrectomy in patients with BMI between 30 and 35 M. Berry MD, P. Lamoza MD, L. Urrutia MD, A. Molina MD, E. Luna MD, F. Parra MD Unit of Bariatric.
Carly Pabon NTR 573 Spring  The different types of bariatric surgery, their prevalence, and effectiveness.  Qualifications for bariatric surgery.
Bariatric Surgery for the Treatment of Obesity and Metabolic Disease
Obesity – Growing epidemic Center for Disease Control and Prevention 2006.
Bariatric Surgery in Obesity and Metabolic Disease Olivier Court MD FRCSC Director, section of Bariatric Surgery McGill University Health Center.
Introducing the Sleeve Gastrectomy Sleeve Gastrectomy as a Bariatric Procedure: Clinical Issues Committee of the American Society for Metabolic and Bariatric.
Patient selection and choosing the optional procedure in bariatric surgery A.R khalaj M.D Minimal Invasive Surgery Research Center university of Iran.
MALABSORPTIVE BARIATRIC SURGERY in Low BMI Korean Patients Ji Yeon Park Soonchunhyang University Seoul Hospital, Korea.
E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.
Safety of Ambulatory Bariatric Surgery Senapati PS, Menon A, Al-Rashedy M, Thawdar P, Akhtar K, Ammori BJ Department of Obesity and Metabolic Surgery Salford.
BARIATRIC (METABOLIC) SURGERY FOR LIFE-LONG WEIGHT CONTROL AND REMISSION OF ASSOCIATED CHRONIC DISEASES – A METAANALYSIS OF PUBLISHED CLINICAL PAPERS TO-DATE.
Complications Associated with Laparoscopic Adjustable Gastric Banding for Morbid Obesity Dr. Mojtaba Hashemzadeh Dr. Leila Zahedi-Shoolami Dr. Mahmoud.
Bariatric Surgery Mr B.M.Axisa Consultant Laparoscopic and Upper GI Surgeon.
L Genser (2), A Soprani(1,2), Tabbara M (2), J Cady (1) 1- Clinique Geoffroy Saint Hilaire (Paris), 2- Service de Chirurgie Digestive et Hépato-Bilio-Pancréatique,
Post-Surgical Care of the Bariatric Patient
Obesity: Surgical Management Eric S. Hungness, M.D. Assistant Professor of Surgery Department of Surgery Northwestern University Feinberg School of Medicine.
Surgical treatment for morbid obesity
THE PRESENCE OF HEPATIC STEATOSIS WHEN NO OTHER CAUSES FOR SECONDARY HEPATIC FAT ACCUMULATION NAFLD MAY PROGRESS TO CIRRHOSIS AND IS LIKELY AN IMPORTANT.
Fight obesity with effective and guaranteed tools t Haitham Al-Khayat, MD Consultant general and bariatric surgeon New Dar Al-Shifa hospital.
The Case Against Bariatric Surgery Centers of Excellence Edward H. Livingston, MD, FACS, AGAF Professor and Chairman, Division of Gastrointestinal Surgery.
MISS Journal Club 2012 Metabolic Surgery & Emerging Technologies Goal: To review 5 important and clinically relevant papers from 2011, on Metabolic Surgery.
Metabolic Effects of Bariatric Surgery on Diabetes Mr Paras Jethwa BSc MD FRCS FRCS(Gen Surg) Consultant Laparoscopic Surgeon.
Ali Ardestani, David Rhoads, Ali Tavakkoli
Obesity Surgery : Is it only for losing weight ? Joint Hospital Surgical Grand Round Simon Chu Prince of Wales Hospital.
Bariatric Surgery and Metabolism Goal: to review 4 important and clinically relevant papers from 2010 on Bariatric Surgery and Metabolism 10/10/20151.
BPD-DS & Sleeve Gastrectomy Journal Club Goal: To review 4 important and clinically relevant papers from 2010 on BPD-DS or Sleeve Gastrectomy 4 papers;
Metabolic and Bariatric Surgery: Expected Outcomes, Merits
Obesity Case Study. What is your history with weight gain and weight loss? Would you like to manage your weight differently? If so, how? What do you think.
DR. RAJESH KHULLAR Senior Consultant
Gastric Bypass: Continuing Issues Walter J. Pories, MD, FACS Professor of Surgery, Biochemistry, Sport and Exercise Science Brody School of Medicine East.
Adolescent Obesity - A Pediatric Surgeon’s Perspective Allen F. Browne, M.D. Adolescent Adjustable Gastric Band Interest Group AAGBIG.
Treatment of GERD in Obese Patients David W Rattner, MD.
September 26, 2008 Colorado Bariatric Surgery Institute Katayun Irani, MD.
Carle Bariatrics Weight Loss Surgery Seminar. Major public health problem worldwide Affects 30% of industrialized world American statistics: – 60% of.
+ Gastric Bypass Complications & Parenteral Nutrition By: Adrienne Gebele.
Bariatric surgery is the surgery to cut off excessive fat from the body.
Sid 1 Juni 2016 Work absenteeism and Gastric bypass: A six-year study Work absenteeism and Gastric bypass: A six-year study Jönsson E 1, Ornstein P 1,2,
Call Us :
Surgical Procedure as a Treatment for Obesity
Castellani RL, Toppino M, Favretto F, Camoglio FS, Zampieri N
Dr. Mojtaba Hashemzadeh Dr. Leila Zahedi-Shoolami
Hippocrates Prize Prof A. Kokkinos (Greece).
STOMACH & DUODENUM-3 Bariatric surgery.
BYPASS GASTRICO DE UNA ANASTOMOSIS (OAGB-BAGUA): RESULTADOS EN UNA
From: Should This Patient Have Weight Loss Surgery
Outcomes of bariatric surgery after renal transplant: single center experience in Kuwait Authors Gheith O, Al-Otaibi T, Nampoory MRN, Halim M, Saied T,
Is the Sleeve Gastrectomy with Jejunal Bypass as good as the Roux-en-Y Gastric Bypass for the treatment of morbid obesity? A comparative study Matías.
“Losing it is only the beginning…” Complications of Bariatric Surgery
Effect of Metabolic Surgery on diabetes and hypertension
(OAGB) “How do I do it” Laparoscopic One Anastomosis Gastric ByPass
Clinical Aspects after Bariatric Procedures in Adolescent: Long Time Follow-Up Nicola Zampieri1, Roberto Castellani2, Marta Peretti1, Federica Bianchi1,
Dr. Siddharth M. SakhiyaDr. Siddharth M. Sakhiya Dr. Natvar PatelDr. Natvar Patel

Electrical Stimulation of the Lower Esophageal Sphincter improves Gastroesophageal Reflux Disease in Patients after Laparoscopic Sleeve Gastrectomy Borbély,
Karlyn A. Martin, MD, Craig R. Lee, PharmD, PhD, Timothy M
Bariatric and metabolic surgery
Volume 15, Issue 2, Pages (August 2008)
Anna Cowell James O’Connell Aintree Weight Management Team
Three-year outcomes of revisional laparoscopic Gastric Bypass after failed laparoscopic Sleeve: A case-matched analysis T. Malinka, J. Zerkowski, Y.
Morbid Obesity Surgery
Outcomes of Roux-en-Y gastric bypass versus sleeve gastrectomy in super-super- obese patients (BMI ≥60 kg/m2): 6-year follow-up at a single university 
Presentation transcript:

Long-term outcomes of bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch D Kröll, Y Borbély, J Altmeier, D Candinas, PC Nett University Obesity Centre Berne Department of Visceral Surgery and Medicine, Inselspital, Berne University Hospital and University of Berne

INTRODUCTION Sleeve gastrectomy (SG) as a single-stage bariatric procedure is becoming increasingly popular Preliminary results have suggested that the weight loss and resolution of comorbidities with SG could be comparable to those with Roux-en-Y gastric bypass (RYGB) or biliopancreatic diversion with duodenal switch (BPD-DS)

AIM OF THE STUDY 1  Long-term % of excess of weight loss (%EWL) in SG, RYGB and BPD-DS 2  Long-term resolution of comorbidities Type 2 diabetes mellitus Hypertension Dyslipidemia OSAS GERD

METHODS Retrospective case-matched analysis (matched for age, sex, preoperative BMI) each arm n=30 Evaluation of %EWL and resolution of comorbidities at 1, 3, and 5 years

PATIENTS P Gender (m/f) Age (years) BMI (kg/m 2 ) 7/23n.s. 36 (23-52) n.s. 44 (38-49) 9/21 41 (21-63) 48 (43-56) n=30/30/30 7/23 39 (27-51) 47 (41-52)

RESULTS %EWL – 1 year P = n. s. 64% 72%61%

RESULTS 70% 75%66% %EWL – 3 years P = n. s.

RESULTS 65% 69%62% %EWL – 5 years P = n. s.

RESULTS Resolution of comorbidities – 1 year Diabetes Hypertension Dyslipidemia 39% – 7/18 71% – 15/21 58% – 11/19 OSAS GERD 59% – 13/22 (21%) – 17/14 68% – 13/19 65% – 13/20 56% – 9/16 58% – 11/19 71% – 15/21 68% – 15/22 61% – 11/18 60% – 12/20 63% – 10/16 23% – 4/17

RESULTS Resolution of comorbidities – 1 year Diabetes Hypertension Dyslipidemia 39% – 7/18 71% – 15/21 58% – 11/19 OSAS GERD 59% – 13/22 (21%) – 17/14 68% – 13/19 65% – 13/20 56% – 9/16 58% – 11/19 71% – 15/21 68% – 15/22 61% – 11/18 60% – 12/20 63% – 10/16 23% – 4/17

RESULTS Resolution of comorbidities – 1 year Diabetes Hypertension Dyslipidemia 39% – 7/18 71% – 15/21 58% – 11/19 OSAS GERD 59% – 13/22 (21%) – 17/14 68% – 13/19 65% – 13/20 56% – 9/16 58% – 11/19 71% – 15/21 68% – 15/22 61% – 11/18 60% – 12/20 63% – 10/16 23% – 4/17

RESULTS Resolution of comorbidities – 3 years Diabetes Hypertension Dyslipidemia 56% – 10/18 57% – 12/21 53% – 10/19 OSAS GERD 50% – 11/22 14% – 2/14 63% – 12/19 55% – 11/20 56% – 9/16 53% – 10/19 76% – 16/21 68% – 15/22 50% – 9/18 50% – 10/20 57% – 9/16 12% – 2/17

RESULTS Resolution of comorbidities – 3 years Diabetes Hypertension Dyslipidemia 56% – 10/18 57% – 12/21 53% – 10/19 OSAS GERD 50% – 11/22 14% – 2/14 63% – 12/19 55% – 11/20 56% – 9/16 53% – 10/19 76% – 16/21 68% – 15/22 50% – 9/18 50% – 10/20 57% – 9/16 12% – 2/17

RESULTS Resolution of comorbidities – 3 years Diabetes Hypertension Dyslipidemia 56% – 10/18 57% – 12/21 53% – 10/19 OSAS GERD 50% – 11/22 14% – 2/14 63% – 12/19 55% – 11/20 56% – 9/16 53% – 10/19 76% – 16/21 68% – 15/22 50% – 9/18 50% – 10/20 57% – 9/16 12% – 2/17

RESULTS Resolution of comorbidities – 5 years Diabetes Hypertension Dyslipidemia 50% – 9/18 48% – 10/21 42% – 8/19 OSAS GERD 50% – 11/22 14% – 2/14 52% – 10/19 40% – 8/20 50% – 8/16 47% – 9/19 71% – 15/21 59% – 13/22 50% – 9/18 45% – 9/20 50% – 8/16 18% – 3/17

RESULTS Resolution of comorbidities – 5 years Diabetes Hypertension Dyslipidemia 50% – 9/18 48% – 10/21 42% – 8/19 OSAS GERD 50% – 11/22 14% – 2/14 52% – 10/19 40% – 8/20 50% – 8/16 47% – 9/19 71% – 15/21 59% – 13/22 50% – 9/18 45% – 9/20 50% – 8/16 18% – 3/17

RESULTS Resolution of comorbidities – 5 years Diabetes Hypertension Dyslipidemia 50% – 9/18 48% – 10/21 42% – 8/19 OSAS GERD 50% – 11/22 14% – 2/14 52% – 10/19 40% – 8/20 50% – 8/16 47% – 9/19 71% – 15/21 59% – 13/22 50% – 9/18 45% – 9/20 50% – 8/16 18% – 3/17

SUMMARY %EWL Long-term results (5 years) Resolutions of comorbidities ✓ ✓ ✓ ✓ ✓ ✓ Symptomatic Reflux/GERD ✓

CONCLUSION SG, RYGB and BPD-DS are comparable in the long-term (5-years) in terms of weight reduction and remission of comorbiditiesis in the treatment of morbid obese patients. However, symptomatic reflux and GERD disease are more often in patients undergoing SG and BPD-DS compared to RYGB